Mefenamic Acid
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
DOWNLOAD PDF HERE
1 DEFINITION
Mefenamic acid contains NLT 98.0% and NMT 102.0% of mefenamic acid (C15H15NO2), calculated on the dried basis.
2 IDENTIFICATION
A. Spectroscopic Identification Tests 〈197〉, Infrared Spectroscopy: 197K or 197A (CN 1-May-2020)
B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
Procedure
Buffer: 50 mM monobasic ammonium phosphate. Adjust with 3 M ammonium hydroxide to a pH of 5.0.
Mobile phase: Acetonitrile, tetrahydrofuran, and Buffer (23:7:20)
Standard solution: 0.2 mg/mL of USP Mefenamic Acid RS in Mobile phase
Sample solution: 0.2 mg/mL of Mefenamic Acid in Mobile phase
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 254 nm
Column: 4.6-mm × 25-cm; 5-μm packing L1
Flow rate: 1 mL/min
Injection volume: 10 μL
System suitability
Sample: Standard solution
Suitability requirements
Column efficiency: NLT 8200 theoretical plates
Tailing factor: NMT 1.6
Relative standard deviation: NMT 0.73%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of mefenamic acid (C15H15NO2) in the portion of Mefenamic Acid taken:
Result = (rU/rS) × (CS/CU) × 100
rU = peak response of mefenamic acid from the Sample solution
rS = peak response of mefenamic acid from the Standard solution
CS = concentration of USP Mefenamic Acid RS in the Standard solution (mg/mL)
CU = concentration of Mefenamic Acid in the Sample solution (mg/mL)
Acceptance criteria: 98.0%–102.0% on the dried basis
4 IMPURITIES
Residue on Ignition 〈281〉: NMT 0.1%
Organic Impurities
Buffer, Mobile phase, and Chromatographic system: Proceed as directed in the Assay.
Standard solution: 0.01 mg/mL of USP Mefenamic Acid RS in Mobile phase
Sensitivity solution: 0.3 μg/mL of USP Mefenamic Acid RS in Mobile phase from the Standard solution
Sample solution: 1 mg/mL of Mefenamic Acid in Mobile phase
System suitability
Samples: Standard solution and Sensitivity solution
Suitability requirements
Tailing factor: NMT 1.6, Standard solution
Relative standard deviation: NMT 5.0%, Standard solution
Signal-to-noise ratio: NLT 10, Sensitivity solution
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of each impurity in the portion of Mefenamic Acid taken:
Result = (rU/rS) × (CS/CU) × 100
rU = peak response of each impurity from the Sample solution
rS = peak response of mefenamic acid from the Standard solution
CS = concentration of USP Mefenamic Acid RS in the Standard solution (mg/mL)
CU = concentration of Mefenamic Acid in the Sample solution (mg/mL)
Acceptance criteria: The reporting threshold is 0.03%.
Any impurity: NMT 0.07%
Total impurities: NMT 0.5%
5 SPECIFIC TESTS
Loss on Drying 〈731〉
Analysis: Dry at 105° for 4 h.
Acceptance criteria: NMT 1.0%
6 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in tight, light-resistant containers.
USP Reference Standards 〈11〉
USP Mefenamic Acid RS

